Document:

DEFINITIVE LICENSE AND DISTRIBUTION AGREEMENT

This Definitive License and Distribution Agreement ("Agreement") is made
effective August 1, 2004 between PEACE MOUNTAIN NATURAL BEVERAGES CORPORATION, a
Massachusetts corporation with an address of P.O Box 1445 Springfield,
Massachusetts 01101-1445 USA (hereinafter "PEACE MOUNTAIN") and Creative
Enterprises International, Inc., a Nevada corporation with an address of 825
Lafayette Road, Bryn Mawr, Pennsylvania 19010 (hereinafter "CREATIVE
ENTERPRISES") regarding the license and distribution of PEACE MOUNTAIN'S Skinny
Water, Diet Water, Skinny Tea, Skinny Juice and Skinny Shake products ("SKINNY
PRODUCTS") by CREATIVE ENTERPRISES.

WHEREAS, PEACE MOUNTAIN has researched and developed at great expense and
represents that it owns all right, title and interest in and to proprietary
information relating to the design, development, manufacture of the SKINNY
PRODUCTS including the good-will, trademarks and trade names associated with the
aforementioned SKINNY PRODUCTS;

     WHEREAS, PEACE MOUNTAIN is offering License and Distribution rights to
CREATIVE ENTERPRISES for the manufacture, distribution and sale of the SKINNY
PRODUCTS on an exclusive basis as further defined hereunder;

     WHEREAS, CREATIVE ENTERPRISES desires to obtain such License and
Distribution right under which it provides the manufacturing, marketing,
promotion, distribution and order fulfillment for the SKINNY PRODUCTS;

CERTAIN INFORMATION HAS BEEN OMITTED FROM THIS EXHIBIT, AS INDICATED BY THE
NOTATION "****", PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT FILED WITH
THE SECURITIES AND EXCHANGE COMMISSION. REDACTED PORTIONS OF THIS EXHIBIT HAVE
BEEN FILED SEPARATELY WITH THE COMMISSION.

NOW, THEREFORE, in view of the foregoing premises and in consideration of the
mutual covenants herein contained, PEACE MOUNTAIN and CREATIVE ENTERPRISES agree
as follows:

RIGHTS GRANTED

     1.1 The Letter of Agreement ("LOA"), Schedule A, between PEACE MOUNTAIN and
     CREATIVE ENTERPRISES dated February 26, 2004 is incorporated by reference
     hereunder. In the event of any conflict of terms between the LOA and this
     Agreement, this Agreement shall govern the parties.

     1.2 PEACE MOUNTAIN grants to CREATIVE ENTERPRISE exclusive License and
     Distribution rights to the SKINNY PRODUCTS for three years as defined in
     the LOA.

     1.3 CREATIVE ENTERPRISES is granted rights to bottle the SKINNY PRODUCTS.
     CREATIVE ENTERPRISES will bottle the SKINNY PRODUCTS either using
     concentrate purchased from PEACE MOUNTAIN or concentrate which it produces
     in accordance with formulations agreed upon with PEACE MOUNTAIN, such
     agreement which shall not be unreasonably withheld. All ingredients shall
     be GRAS.

     1.4 PEACE MOUNTAIN grants a right of first refusal to CREATIVE ENTERPRISES
     to enter into a license and distribution agreement for future SKINNY
     PRODUCTS on same terms and conditions as mutually agreed upon by the
     parties. CREATIVE ENTERPRISES shall have 30 days after receiving notice
     from PEACE MOUNTAIN of PEACE MOUNTAIN'S intention to place the newly
     developed SKINNY PRODUCTS on the market to enter into a definitive license
     agreement for such additional SKINNY PRODUCTS otherwise it shall be deemed
     to have declined to exercise its right.

MARKETING EFFORTS

     2.1 CREATIVE ENTERPRISES agrees to use reasonable efforts to market PEACE
     MOUNTAIN'S SKINNY PRODUCTS continuously during the term of this Agreement,
     and any subsequent renewals thereof using commercially acceptable practices
     consistent with the ordinary course of business for similar products in the
     industry while following sound business judgment.

     2.2 CREATIVE ENTERPRISES has spent nearly [****] to-date since the signing
     of the LOA in the areas of label design, legal review of the labels,
     setting up national warehouse and trucking infrastructure, publicity and
     the hiring of distributors.

[*Certain information on this page has been omitted and filed separately with
the Commission. Confidential treatment has been requested with respect to the
omitted portions.]

     2.3 CREATIVE ENTERPRISES plans to spend an additional [****] in marketing
     and promotion during the remainder of 2004 and during 2005 to launch the
     SKINNY PRODUCTS. The expenditures to used for travel/entertainment
     expenses, distributor commissions and advance payments, focus groups,
     samples, branding, trade show exhibits, distributor sales meeting,
     sponsored events, trade advertising, web promotions oriented at customer
     loyalty, and sales activities to cultivate national retailers such as
     Target, 7-11, Albertson's, and Walgreens.

     2.4 CREATIVE ENTERPRISES plans to complete the various milestones as
     defined on SCHEDULE D for a launch of the SKINNY PRODUCTS during the
     2004-2005 timeperiod. The events and timelines on SCHEDULE D are for
     planning purposes and subject to change based on actual market conditions.

TERM

     3.1 The term of this Agreement shall be for an initial period of three (3)
     years commencing on the effective date and shall automatically renew for
     additional one year terms under the same terms and conditions contained
     herein. Said renewals to take effect automatically following the expiration
     of the previous term unless terminated as provided hereunder.

TERMINATION

     4.1 PEACE MOUNTAIN may terminate this Agreement for cause if:

          i.   commencing no later than January 2005 CREATIVE ENTERPRISES shall
               bottle SKINNY PRODUCTS, such amount bottled increasing
               periodically thereafter such that no later than December 2005 the
               ongoing run-rate representing the average weekly quantity
               bottled shall equate to the amount necessary to produce [****]
               bottles of [****] size ("Minimum Purchase Amount"); or

          ii.  in subsequent renewal terms, CREATIVE ENTERPRISES fails to bottle
               weekly in a ongoing average monthly run-rate a quantity of the
               SKINNY PRODUCTS which is [****] greater than the Minimum Purchase
               Amount for the preceding period; or

          iii. CREATIVE ENTERPRISES materially breaches any obligation under
               this Agreement and/or the LOA and such breach remains uncured
               after thirty (30) days.

     4.2 The obligations of confidentiality of Paragraph 9 shall survive the
     term of this agreement until one of the exceptions of Paragraph 9.5 shall
     apply.

     4.3 CREATIVE ENTERPRISES may cure a breach of this Agreement for failure to
     bottle the Minimum Purchase Amount under 4.1 (i) or 4.1 (ii) by making a
     payment

[*Certain information on this page has been omitted and filed separately with
the Commission. Confidential treatment has been requested with respect to the
omitted portions.]

     to PEACE MOUNTAIN in the amount of $10,000 for each month where CREATIVE
     ENTERPRISES is in breach of the aforementioned performance criteria.

     ROYALTIES AND COMPENSATION.

     5.1 If CREATIVE ENTERPRISES purchases the concentrate for SKINNY PRODUCTS
     from PEACE MOUNTAIN, CREATIVE ENTERPRISES shall pay PEACE MOUNTAIN the
     factory cost for the concentrate. Factory cost shall include the cost of
     the actual ingredients plus reasonable and ordinary direct expenses
     attributable to PEACE MOUNTAIN'S production costs including but not limited
     to packaging costs, labor, overhead, shipping and other related expenses
     involved in the production of concentrate.

     5.2 PEACE MOUNTAIN'S compensation from CREATIVE ENTERPRISES for the License
     and Distribution rights granted shall be [****] of the Gross Profits
     generated from the sale of the SKINNY PRODUCTS. Gross Profit shall mean
     revenue collected less [****]. Marketing and direct sales expenses shall be
     based on the [****] paid to third parties [****] by CREATIVE ENTERPRISES.
     Gross Profits shall be paid on at least a calendar year basis but
     calculated and reserved on the books of CREATIVE ENTERPRISES at quarterly
     intervals.

     5.3 During the period of August 1, 2004 through December 31, 2005, CREATIVE
     ENTERPRISES shall pay to PEACE MOUNTAIN advances against its share of the
     GROSS PROFITS. The amount of the advance each month shall be [****] for
     August 2004 through December 2004, and shall increase in January 2005 to
     [****] per month for the remaining months through December 2005. All
     payments shall be made in advance on the first day of each month.

     All payments shall be non-recourse advances against PEACE MOUNTAIN'S profit
     share for the period August 2004 through December 2005. Advance payments
     made by CREATIVE ENTERPRISES during the period can only be offset against
     profits owed to PEACE MOUNTAIN during the August 2004 through December 2005
     period. If the actual profits owed by CREATIVE ENTERPRISES for the period
     exceed the amount advanced to PEACE MOUNTAIN, then CREATIVE ENTERPRISES
     shall be obligated only to pay any amounts which exceed the total of the
     advance payments. If the actual profits are less than the total amount of
     all advance payments made by CREATIVE ENTERPRISES, PEACE MOUNTAIN shall not
     be obligated to repay or credit the shortfall against profits earned in
     subsequent periods.

[*Certain information on this page has been omitted and filed separately with
the Commission. Confidential treatment has been requested with respect to the
omitted portions.]

     5.4 All shipments of concentrate by PEACE MOUNTAIN to CREATIVE ENTERPRISES
     shall be F.O.B Worcester, MA or any other shipping point selected by PEACE
     MOUNTAIN which is equal or a lesser distance from CREATIVE ENTERPRISES'
     offices.

     5.5 CREATIVE ENTERPRISES shall reimburse PEACE MOUNTAIN for PEACE
     MOUNTAIN'S out of pocket expenses related to the development and
     modification of the SKINNY PRODUCTS, legal expenses for license agreements
     and protection of intellectual property (including costs for foreign
     trademark registrations which shall commence upon the signing of this
     Agreement), and other expenses incurred at the bequest of CREATIVE
     ENTERPRISES associated with the introduction of the SKINNY PRODUCTS
     including but not limited to travel and entertainment expenses. Reimbursed
     expenses shall be directly related to this Agreement and payable upon
     presentation of actual copies of invoices or bills.

     RECORDS AND INSPECTION

     6.1 CREATIVE ENTERPRISES shall provide to PEACE MOUNTAIN on a quarterly
     basis reporting which indicates its plans for the upcoming three month for
     the marketing and promotion of the SKINNY PRODUCTS.

     6.2 CREATIVE ENTERPRISES shall provide to PEACE MOUNTAIN on a quarterly
     basis a report of the actual marketing and promotion expenditures for the
     previous three month period.

     6.3 PEACE MOUNTAIN shall have the right upon reasonable notice to CREATIVE
     ENTERPRISES to inspect the records of CREATIVE ENTERPRISES for the purposes
     of reviewing any contracts or other agreements for which CREATIVE
     ENTERPRISES has entered which affects the sale, marketing, distribution or
     manufacture of the SKINNY PRODUCTS.

     6.4 PEACE MOUNTAIN shall have the right to periodically inspect samples of
     the bottled SKINNY PRODUCTS to ensure that the SKINNY PRODUCTS are
     consistent with PEACE MOUNTAIN'S formulation.

     6.5 CREATIVE ENTERPRISES shall provide to PEACE MOUNTAIN on a quarterly
     basis accounting indicating the quantity of SKINNY PRODUCTS produced and
     shipped for the previous period.

     TRADEMARKS AND COPYRIGHTS

     7.1 Throughout the term of this Agreement, CREATIVE ENTERPRISES shall have
     the right to utilize PEACE MOUNTAIN'S trademarks and copyrights for the
     SKINNY PRODUCTS for exclusive purpose of promoting and selling the SKINNY
     PRODUCTS. PEACE MOUNTAIN grants to CREATIVE ENTERPRISES an

     exclusive license to use the aforementioned trademarks and trade names
     ("MARKS") associated with the SKINNY PRODUCTS for the sole purpose of
     promoting, selling and distributing the SKINNY PRODUCTS. Notwithstanding
     such exclusive license of the MARKS to CREATIVE ENTERPRISES, PEACE MOUNTAIN
     shall retain all its existing rights of use and ownership in the MARKS.

     7.2 Such MARKS are listed on Schedule C. CREATIVE ENTERPRISES will submit
     to PEACE MOUNTAIN any proposed use of the MARKS for PEACE MOUNTAIN'S
     approval prior to commencing such use.

     7.3 CREATIVE ENTERPRISES will submit to PEACE MOUNTAIN copies of all uses
     of PEACE MOUNTAIN'S trademarks and copyrights including but not limited to
     advertisements, promotional materials or any other use.

     7.4 CREATIVE ENTERPRISES shall have the right to modify and revise
     promotional materials, labeling and packaging of the SKINNY PRODUCTS
     provided that any such modifications or revisions do not adversely affect
     the PEACE MOUNTAIN trademarks, trade names or good-will associated with the
     MARKS.

     7.5 CREATIVE ENTERPRISES shall identify all SKINNY PRODUCTS and promotional
     materials including any web sites:

          (a)  as bottled under license from PEACE MOUNTAIN with following
               language appearing on the PRODUCT label and in conjunction will
               all advertising or web promotion:

               "bottled under license from Peace Mountain Natural Beverages
               Corp."

          (b)  and identifying PEACE MOUNTAIN's rights in the trademark "Skinny
               Water" on the PRODUCT label and all marketing materials as
               follows:

               "Skinny Water" is registered trademark of Peace Mountain Natural
               Beverages Corporation"

     NON- COMPETITION

     8.1 CREATIVE ENTERPRISES agrees not to reverse engineer, determine the
     formulation of or copy in any other form or manner PEACE MOUNTAIN'S SKINNY
     PRODUCTS.

     8.2 CREATIVE ENTERPRISES agrees that during the term of this Agreement it
     will not distribute any other product that may be a competitive product to
     the SKINNY PRODUCTS. Competitive products for the purposes of this
     Agreement shall mean any enhanced water product offering weight loss.

     CONFIDENTIAL INFORMATION

     9.1 PEACE MOUNTAIN may disclose certain of its confidential information
     such as formulations for the SKINNY PRODUCTS and other non-public
     information, technical data, financial information, corporate practices,
     procedures and other data owned or used by it, which, together with all
     photographs, copies, reproductions, extractions, tracings, outlines,
     paraphrasing, bulletins, memoranda, manuals, records, summaries, letters,
     books and notes in which the same may be embodied it considers to be
     proprietary information ("TRADE SECRETS").

     9.2 CREATIVE ENTERPRISES agrees that any TRADE SECRETS disclosed hereunder
     shall be and remain exclusively the property of PEACE MOUNTAIN and shall be
     held in the strictest confidence by CREATIVE ENTERPRISES. No TRADE SECRETS
     may be disclosed or delivered to others (other than employees, consultants
     and representatives of CREATIVE ENTERPRISES with a need to know, provided
     that such persons agree to abide by the terms of confidentiality of this
     Agreement with respect to PEACE MOUNTAIN'S TRADE SECRETS received by such
     person) or used by the party receiving it for any purpose (other than the
     limited purpose of performance of rights granted in this Agreement) without
     the prior written consent of PEACE MOUNTAIN.

     9.3 Except as necessary for the performance of the limited purpose as
     contemplated by this Agreement or as expressly authorized in writing by
     PEACE MOUNTAIN, CREATIVE ENTERPRISES, or any party receiving such TRADE
     SECRETS from CREATIVE ENTERPRISE, agrees that it will not copy, take
     noteof, photograph, outline, summarize, reproduce in any way, disclose or
     use the TRADE SECRETS or any part thereof and that such party will return
     to PEACE MOUNTAIN, upon PEACE MOUNTAIN'S request, all documents provided by
     PEACE MOUNTAIN and all copies, summaries, notes and outlines thereof.

     9.4 CREATIVE ENTERPRISES hereto shall take reasonable measures to prevent
     unauthorized disclosure of TRADE SECRETS and treat such TRADE SECRETS with
     at least the degree of care that it would for its own proprietary
     Information. Notwithstanding, CREATIVE ENTERPRISES shall use at minimum
     upmost care in protecting the confidentiality of TRADE SECRETS.

     9.5 The obligations of confidentiality set forth in this Agreement shall
     not apply to:

                    a. Information which is in the public domain as of the date
          of this Agreement or which later comes into the domain from a source
          other than any party hereto receiving it pursuant to this Agreement;

                    b. Information approved for release by written authorization
          of PEACE MOUNTAIN;

                    c. Information rightfully acquired by a party on a non-
          confidential basis from a third party having a right to disclose the
          same;

                    d. Information rightfully known to a party prior to receipt
          of the proprietary information and

                    e. Information developed by a party subsequent to the date
          of disclosure hereunder without reliance on any proprietary
          information of the other party except to the extent of such party's
          right to use such information.

     9.6 CREATIVE ENTERPRISES may disclose TRADE SECRETS and other Proprietary
     Information received from PEACE MOUNTAIN to the extent legally compelled to
     do so by any order, subpoena or document discovery request provided that
     prior to disclosure, written notice of such disclosure is furnished to the
     PEACE MOUNTAIN as soon as practicable in order to afford PEACE MOUNTAIN an
     opportunity to seek a protective order (it being agreed that if PEACE
     MOUNTAIN is unable to obtain or does not seek a protective order and
     CREATIVE ENTERPRISES is legally compelled to disclose such information,
     disclosure of such information may be made without liability).

     9.7 These obligations of confidentiality shall supplement and supercede any
     conflicting provisions in the any confidentiality agreement executed by the
     parties prior to the signing of this Agreement including but not limited to
     the confidentiality agreement dated February 12, 2004 which is attached as
     Schedule B.

DISCLAIMERS AND WARRANTIES

     10.1 PEACE MOUNTAIN warrants that it has the right, title and interest in
     the SKINNY PRODUCTS and has the right to grant the license made hereunder,
     but it makes no warranty or representation that said licensed copyright nor
     that any product manufactured pursuant to this Agreement will not infringe
     upon the patent or rights of another.

     LIMITATION OF LIABILITY. NEITHER SPECIAL, INCIDENTIAL OR CONSEQUENTIAL
     DAMAGES SUFFERED BY A PARTY SHALL BE LIABLE FOR ANY OTHER PARTY, ANY OF ITS
     AFFILIATES, ANY OF ITS SUBLICENSEES OR ANY THIRD PARTY ARISING OUT OF, OR
     IN CONNECTION WITH, THE LICENSE OR USE OF THE TECHNOLOGY OR SALE OR USE OF
     ANY LICENSED PRODUCT. IN ADDITION TO THE FOREGOING, NEITHER LICENSOR NOR
     LICENSEE SHALL BE LIABLE TO THE OTHER FOR ANY SPECIAL, INCIDENTAL OR
     CONSEQUENTIAL DAMAGES SUFFERED BY THE OTHER PARTY, ANY AFFILIATE OR

     SUBLICENSE OF THE OTHER OR ANY THIRD PARTY ARISING OUT OF, OR IN CONNECTION
     WITH, THIS AGREEMENT, THE PERFORMANCE BY EITHER PARTY OF ANY OF ITS
     OBLIGATIONS HEREUNDER, ANY REPRESENTATION OR WARRANTY OF EITHER PARTY
     HEREUNDER OR OTHERWISE, EXCEPT ANY SUCH DAMAGES WHICH ARISE OUT OF, OR
     RESULT FROM, ANY INTENTIONAL AND KNOWING BREACH OF THIS AGREEMENT. THE
     FOREGOING LIMITATIONS APPLY TO ALL CLAIMS, INCLUDING, WITHOUT LIMITATION,
     BREACH OF CONTRACT, BREACH OF WARRANTY, NEGLIGENCE, STRICT LIABILITY,
     MISREPRESENTATION OR OTHER TORTS.

     NOTWITHSTANDING ANYTHING IN THIS AGREEMENT TO THE CONTRARY, THE FOREGOING
     IS IN LIEU OF ALL WARRANTIES, EXPRESS OR IMPLIED, WHENEVER ARISING BY LAW,
     CUSTOM OR CONDUCT. IN NO EVENT SHALL LICENSOR BE LIABLE FOR INDIRECT OR
     CONSEQUENTIAL DAMAGES.

NOTICES

     11.1 All notices and other communications hereunder shall be in writing and
     shall be deemed given if delivered personally or by facsimile transmission
     (receipt verified), telexed, mailed or registered or certified mail (return
     receipt requested), postage prepaid, or sent by express courier service, to
     the Parties at the following addresses (or at such other address for a
     Party as shall be specified by like notice; provided, that notices of a
     change of address shall be effective only upon receipt thereof):

          If to PEACE MOUNTAIN addressed to:

          John David Alden
          Peace Mountain Natural Beverages Corp.
          57 Cooley Drive
          Longmeadow, MA 01106-1397

          If to CREATIVE ENTERPRISES addressed to:

          Michael Salaman
          Creative Enterprises International, Inc.
          825 Lafayette Road
          Byrn Mawr, PA 19010-1816

SEVERABILITY

     12.1 If any section, paragraph or subparagraph of this Agreement or any
     portion hereof is held to be indefinite, invalid, illegal or otherwise
     void, voidable or unenforceable, the same shall be severable and severed
     from this Agreement, and the balance of the Agreement shall continue in
     full force and effect. If any provision of this Agreement conflicts with
     any present or future statute, bylaw, ordinance or regulation, contrary to
     which the parties have no legal right to contract, or if any provision of
     this Agreement is deemed unreasonable, then the parties hereto agree that
     such provision shall be curtailed and limited to the extent necessary and
     bring it within the requirements of the law, and the Agreement shall remain
     valid and enforceable, and the parties to be bound by and perform this
     Agreement as thus modified.

DISPUTE RESOLUTION

     13.1 In the event any dispute or controversy arises out of or in connection
     with this Agreement, the Parties agree to exercise their best efforts to
     resolve the dispute or controversy as soon as possible within sixty (60)
     days of notice from one party to the other of such dispute or controversy.
     The Parties shall, without delay, continue to perform their respective
     obligations under this Agreement which are not affected by such dispute or
     controversy. With the exception of instances in which irreparable harm is
     imminent, the Parties shall first attempt to resolve the dispute in the
     aforementioned manner.

     13.2 However, if either Party fails or refuses to participate in such
     negotiations, or if, in any event, the dispute, controversy or claim is not
     resolved to the satisfaction of both Parties within the sixty (60) day
     period, any such dispute, controversy or claim shall be settled by
     arbitration. Any such arbitration shall be conducted in accordance with the
     rules of the American Arbitration Association and shall take place in
     Springfield, Massachusetts. The Agreement shall be governed by and
     construed in accordance with the laws of the Commonwealth of Massachusetts
     and the United States of America. The arbitrators shall include one
     independent, unaffiliated nominee selected by each Party and a third
     neutral arbitrator selected by such nominees. The Parties agree that any
     arbitration panel shall include members knowledgeable as to the beverage
     industry. Judgment upon the award rendered may be entered in the highest
     state or federal court or forum, state or federal, having jurisdiction. The
     prevailing Party shall be entitled to reasonable attorney's fees and costs
     to be fixed by the arbitrators.

MISCELLANEOUS

     14.1 Applicable Law. This Agreement shall be governed by the Commonwealth
     of Massachusetts.

     14.2 Forum and Venue. Any legal action or proceeding with respect to this
     Agreement may be brought in the courts of the Commonwealth of Massachusetts
     or any United States District Court in such State, and the parties hereby
     irrevocably consent to the jurisdiction of such courts for the purpose of
     any action or proceeding and waive any claim of lack of jurisdiction or
     forum non conviens.

     14.3 Assignability. Neither party hereto shall, without prior written
     consent of the other party, assign this Agreement or any other right or
     obligation hereunder. However, either party reserves the right to assign
     this Agreement to a successor of substantially the entire business to which
     this Agreement relates or to any Affiliate provided that such successor or
     such Affiliate as the case may be agrees in writing to be bound by all of
     the terms of this Agreement.

     14.4 Successors and Assigns. This Agreement shall bind and inure to the
     benefit of the Parties hereto and their respective successors and permitted
     assigns, but nothing contained herein shall be deemed to permit assignment
     by either Party except as otherwise permitted in this Agreement.

     14.5 Entire Agreement. This Agreement supersedes all prior Agreements,
     understandings and arrangements; oral or written, among the parties. This
     Agreement shall be amended only by written agreement between the Parties.
     The provisions of this Agreement will be construed as agreements which are
     independent of any other agreement between the parties hereto and the
     existence of any claim or cause of action by either of them against the
     other, whether predicated on this or any other agreement, shall not
     constitute a defense or offset to the enforcement of the covenants
     contained in this Agreement.

     14.6 Force Majeure. If either party is prevented from or delayed in
     carrying out any of the provisions of this Agreement by reasons of any acts
     of God, war, accidents, labor disturbances, break-down of plant equipment,
     lack or failure of transportation facilities, source of supply of labor,
     raw materials, power or supplies, or by reasons of any law, order
     proclamation, regulation, ordinance, demand or requirement of any
     Government or any subdivision, authority or representatives of any such
     Government, or by reason of any other cause whatsoever beyond the
     reasonable control of the party, preventing or delayed the performance of
     its obligations hereunder, the party so presented in or delayed shall be
     excused from such performance to the extent and during the period of such
     prevention or delay, without, however, extending the terms of this
     Agreement. Any obligation to pay money shall in no event be excused but
     shall be suspended only until the cessation of any cause of prevention from
     or delay in the performance of such obligation.

     14.7 No Partnership. Nothing in this Agreement shall be deemed to
     constitute a partnership between the parties nor shall either party be
     taken to have any authority to bind or commit the other or be taken to have
     authority to act as the agent of the other or in any other capacity other
     than as expressly authorized in this Agreement. No Waiver. No waiver of any
     right under this Agreement shall be deemed effective unless the same is set
     forth in a writing signed by the party giving such waiver, and

     no waiver of any right shall be deemed to be a waiver of such right, or any
     other rights hereunder, in the future.

ENTIRE AGREEMENT

     15.1 The foregoing contains the entire and only Agreement between the
     parties regarding this Agreement. All prior and collateral representations,
     promises or conditions in connection with the subject matter are merged
     herein. Any representation, promise or condition not incorporated herein
     shall not be binding on either party.

     15.2 This agreement shall not be amended, modified or changed, except by
     written instrument signed by the parties. The Parties acknowledge, execute
     and deliver all such further documents, instruments or assurances and to
     perform all such acts or deeds as may be reasonably required from time to
     time in order to carry out the terms of this Agreement

IN WITNESS WHEREOF, PEACE MOUNTAIN and CREATIVE ENTERPRISES have executed this
Agreement intending to be legally bound thereby, as of the effective date first
above set forth.

PEACE MOUNTAIN NATURAL BEVERAGES CORPORATION

By: /s/ John David Alden
    ----------------------------------
Dated: August 4, 2004

CREATIVE ENTERPRISES INTERNATIONAL, INC

By: /s/ Michael Salaman
    ----------------------------------
Dated: August 4, 2004

                                   SCHEDULE A

       LETTER OF AGREEMENT BETWEEN PEACE MOUNTAIN AND CREATIVE ENTERPRISES
                             DATE FEBRUARY 26, 2004

                               LETTER OF AGREEMENT

          This Letter of Agreement ("LOA") sets forth the basic agreement
between Peace Mountain Natural Beverage ("PEACE MOUNTAIN") and Creative
Enterprises International, Inc. ("CREATIVE ENTERPRISES"), collectively referred
to hereafter as the PARTIES, regarding agreements concerning the license and
distribution of PEACE MOUNTAIN'S Skinny Water products ("PRODUCTS") by CREATIVE
ENTERPRISES. The PARTIES recognize that there may be further additional terms
and conditions to be incorporated in a definitive License and Distribution
Agreement ("AGREEMENTS"). Each party intends to be bound by the following terms
and conditions in this LOA and such definitive Agreements when are formally
executed by the PARTIES.

     WHEREAS, PEACE MOUNTAIN has researched and developed at great expense and
represents that it owns all right, title and interest in and to proprietary
information relating to the design, development, manufacture of the PRODUCTS
including the good-will, trademarks and trade names associated with the
aforementioned PRODUCTS;

     WHEREAS, PEACE MOUNTAIN is offering License and Distribution rights to
CREATIVE ENTERPRISES for the manufacture, distribution and sale of the PRODUCTS
on an exclusive basis as further defined hereunder;

     WHEREAS, CREATIVE ENTERPRISES desires to obtain such License and
Distribution right under which it provides the manufacturing, marketing,
promotion, distribution and order fulfillment for the PRODUCTS;

          THEREFORE, the parties set forth the following general terms:

1. PEACE MOUNTAIN grants to CREATIVE ENTERPRISE exclusive License and
Distribution rights to the PRODUCTS worldwide for three years. Notwithstanding
such grant of exclusivity, PEACE MOUNTAIN shall retain the right to sell to the
specific customers identified in Schedule A ("HOUSE ACCOUNTS").

2. Under the License rights, CREATIVE ENTERPRISES shall purchase from PEACE
MOUNTAIN concentrate for the PRODUCTS and CREATIVE ENTERPRISES will contract for
the bottling of the PRODUCTS, such bottling to use the concentrate purchased
from PEACE MOUNTAIN and in the formulation prescribed by PEACE MOUNTAIN.

3. PEACE MOUNTAIN provides concentrate to CREATIVE ENTERPRISES at the cost of
$[xxx] FOB shipping point. One gallon of concentrate will yield approx, [xxx]
gallons of retail product. The purchase of the concentrate by CREATIVE
ENTERPRISES will be the license royalty payment to PEACE MOUNTAIN.

4. PEACE MOUNTAIN may disclose certain of its confidential information such as
formulations for the PRODUCTS and other information it considers to be
proprietary information ("TRADE SECRETS"). CREATIVE ENTERPRISES has entered into
a Confidentiality Agreement (Schedule B) with PEACE MOUNTAIN in order to protect
the TRADE SECRETS of PEACE MOUNTAIN. CREATIVE ENTERPRISES shall ensure that all
vendors and sub-contractors who receive PEACE MOUNTAIN's confidential
information shall enter into and be bound by the Confidentiality Agreement
between CREATIVE ENTERPRISES and PEACE MOUNTAIN.

5. The initial term of this LOA and the License and Distribution Agreements
shall be for a period of three years commencing from the date entered on the
signature lines below. The License and Distribution Agreements will be renewed
for additional one year terms with the minimum quantity increasing in each
renewal term by [xxx] above the prior term.

6. This LOA, and the License and Distribution Agreements shall terminate prior
to the three year term, or during any subsequent renewal term, if CREATIVE
ENTERPRISES fails to sell a minimum weekly volume of the PRODUCTS which is
equivalent to [xxx] bottles of [xxx] size during the initial term or the
adjusted higher minimum quantities for subsequent renewal terms, as provided in
Paragraph 5. The minimum weekly volume shall become effective six months after
the signing of the LOA.

[* Certain information on this page has been omitted and filed separately with
the Commission. Confidential treatment has been requested with respect to the
omitted portions.]

7. CREATIVE ENTERPRISES will not enter into any License or Distribution
Agreements, market, promote or otherwise sell any products which are competitive
to the PRODUCTS. Competitive products for the purposes of this Agreement shall
mean any enhanced water product offering beauty, weight loss and/or energy
improvement attributes.

8. PEACE MOUNTAIN grants to CREATIVE ENTERPRISES a first right of refusal on
future Peace Mountain products subject to terms and conditions to be negotiated
at that time; however the intention of the PARTIES is to have terms consistent
with this LOA and the AGREEMENTS.

9. CREATIVE ENTERPRISES will submit an outline of its proposed marketing efforts
within 60 days of signing the LOA. These marketing efforts will initially
include but not be limited to focus groups and market research intended to
determine market acceptance and opportunity for the PRODUCTS.

10. Prior to or at the time of signing the AGREEMENTS, CREATIVE ENTERPRISES will
submit to PEACE MOUNTAIN a comprehensive business and marketing plan. CREATIVE
ENTERPRISE estimates at this time to the best of its ability that it will invest
from [xxx] during the first months after signing the AGREEMENTS for promotion of
the PRODUCTS.

11. PEACE MOUNTAIN grants to CREATIVE ENTERPRISES an exclusive license to use
its trademarks and trade names ("MARKS") associated with the PRODUCTS for the
sole purpose of promoting, selling and distributing the PRODUCTS.
Notwithstanding such exclusive license of the MARKS to CREATIVE ENTERPRISES,
PEACE MOUNTAIN shall retain all its existing rights in the MARKS.

Such MARKS are listed on Schedule C. CREATIVE ENTERPRISES will submit to PEACE
MOUNTAIN any proposed use of the MARKS for PEACE MOUNTAIN'S approval prior to
commencing such use.

12. CREATIVE ENTERPRISES shall have the right to modify and revise promotional
materials, labeling and packaging of the PRODUCTS provided that any such
modifications or revisions do not adversely affect the PEACE MOUNTAIN
trademarks, trade names or good-will associated with the MARKS.

13. PEACE MOUNTAIN'S compensation from CREATIVE ENTERPRISES for the Distribution
rights granted shall be [xxx] of the Gross Profits generated from the sale of
the PRODUCTS. Gross Profit shall mean revenue collected less cost of goods sold,
marketing and direct sales expenses, but before all taxes and general
administrative expenses. Marketing and direct sales expenses shall be based on
the actual cost paid to third parties without any additional mark-up by CREATIVE
ENTERPRISES.

[* Certain information on this page has been omitted and filed separately with
the Commission. Confidential treatment has been requested with respect to the
omitted portions.]

14. In the event either of the PARTIES breaches or fails to perform its
obligations ("BREACH") under the LOA, the party alleging the BREACH shall notify
in writing the breaching party and provide the breaching party with 30 days to
cure such breach. If such breach has not been cured within 30 days, the party
alleging the breach may terminate its obligations under the LOA and the
AGREEMENTS by delivering written notification to the other party.

16. The PARTIES are issuing this LOA on the understanding that this LOA is
binding on each party hereto and that it may be supplemented with the addition
of a mutually acceptable License and Distribution Agreements.

17. This Letter of Agreement shall be governed by the laws of the Commonwealth
of Massachusetts and any action relating to this agreement shall be brought in
Springfield, Massachusetts in the United States District Court for the District
of Massachusetts.

                Agreed and Accepted on the date indicated below:

                CREATIVE ENTERPRISES INTERNATIONAL INC.

                /s/ Michael Salaman
                --------------------------
                Michael Salaman
                Its: CEO President
                Date: 2-26-04

                PEACE MOUNTAIN NATURAL BEVERAGES CORP.

                /s/ John David Alden
                --------------------------
                John David Alden
                Its: President
                Date: FEB. 26, 2004

                                   SCHEDULE A

                        PEACE MOUNTAIN "HOUSE ACCOUNTS":

                                  SCHEDULE B -

                CONFIDENTIALITY AGREEMENT DATE FEBRUARY 12, 2004

                        SCHEDULE C - TRADEMARKS LICENSED

SKINNY SHAKE   U.S. Reg. No. 2743268

SKINNY WATER   U.S. Reg. No. 2557075

SKINNY TEA     U.S. Reg. No. 2657057

SKINNY JUICE   U.S. Reg. No. 2657083

DIET WATER     U.S. Reg. No. 2576866"SUPER CITRIMAX(R) CLINICAL STRENGTH"
                               LICENSING AGREEMENT

This Licensing Agreement ("Agreement") is entered into as of June 7, 2004
("Effective Date"), between InterHealth Nutraceuticals Incorporated, a
California corporation ("Company"), and the licensee identified on the signature
page of this Agreement ("Licensee").

WHEREAS, Company markets, distributes and sells a standardized calcium/potassium
(-)hydroxycitric acid product described in Exhibit A attached hereto
("Product"), which:

     (a)  is sold as nutritional supplement,

     (b)  is the subject of various U.S. and PCT patents pending described in
          Exhibit A attached hereto, as well as other patents pending, which may
          be applied for in the future ("Patents Pending"),

     (c)  is the subject of various research studies described in Exhibit B
          attached hereto, as well as other research studies, which may be
          conducted and published in the future ("Research"),

     (d)  is the subject of various product claims covered by the Patents
          Pending and supported by the Research ("Product Claims"), and

     (e)  is sold under the tradename "Super CitriMax Clinical Strength"
          ("Trademark")

("Licensed Product").

WHEREAS, A) Company is the owner of all right, title and interest in the (i)
Patents Pending, including any continuation-in-parts, divisional and reissue
applications, and any patents resulting therefrom ("Patent Rights"), and (ii)
Trademark, including variations thereof and any registrations which may exist
therefore, for its Licensed Product, B) Licensee desires to sell, market and
distribute finished product(s) that contain Licensed Product to be packaged by
Licensee in end-user, finished packaged form as a nutritional supplement (each a
"Finished Product," collectively "Finished Products"), and to use the Trademark,
Product Claims and Research in connection with sales of its Finished Products;
and C) Company is willing to (i) sell Product to Licensee, or Licensee's
designated contract manufacturer(s), and (ii) grant Licensee the right to use
the Trademark, Product Claims and Research in connection with the sale of
Licensee's Finished Products.

NOW, THEREFORE, the parties agree as follows:

     1.   TRADEMARK OWNERSHIP - Licensee agrees that:

          (a)  Company is the sole and exclusive owner of all right, title and
               interest in, and to, the Trademark and Patent rights;

          (b)  Licensee shall not challenge or question the validity of, or
               Company's title to, the Trademark or Patent Rights; and

          (c)  with the exception of the rights being licensed under this
               Agreement, all other rights relating to the Trademark and Patent
               Rights are the property of the Company and Licensee shall not
               acquire any other rights to the Trademark or Patent Rights.

     2.   BUY/SELL AGREEMENT - Company agrees to sell Product to Licensee or
          Licensee's designated contract manufacturer(s) of Finished Products
          (each a "Contract Manufacturer," collectively "Contract
          Manufacturers"), and Licensee or Licensee's Contract Manufacturers,
          whichever the case may be, agree to purchase Product exclusively from
          Company at prices, terms and conditions acceptable to Company and
          Licensee and/or Licensee's Contract Manufacturers, whichever the case
          may be, and other terms and conditions specified in this Agreement.

     3.   GRANT OF LICENSE - Company grants to Licensee, and Licensee accepts, a
          non-exclusive, non-transferable, royalty-free license to use the
          Trademark, Product Claims and Research solely in connection with the
          marketing and distribution of Finished Products that contain Product
          in the manner, and on the terms and conditions, specified in this
          Agreement. InterHealth represents that to the best of its knowledge,
          information, and belief (a) the Research has been conducted in
          accordance with good scientific standards and practices, and (b) the
          Product Claims are substantiated by the Research.

     4.   USE OF TRADEMARK - Licensee shall:

          (a)  use the Trademark, Product Claims and Research solely in
               connection with:

               (i)  the Licensed Product purchased from Company, and

               (ii) Finished Product that is in compliance with this Agreement;

          (b)  display the Trademark on, or in, all labeling, advertising and
               promotional

CERTAIN INFORMATION HAS BEEN OMITTED FROM THIS EXHIBIT, AS INDICATED BY THE
NOTATION "****", PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT FILED WITH
THE SECURITIES AND EXCHANGE COMMISSION. REDACTED PORTIONS OF THIS EXHIBIT HAVE
BEEN FILED SEPARATELY WITH THE COMMISSION.

               materials of its Finished Products in a manner that clearly
               associates the Trademark with the licensed Product;

          (c)  display or reproduce the Trademark only in:

               (i)  the appropriate logo style specified in Exhibit C attached
                    to this Agreement (electronic file of the Trademark logo to
                    be provided to Licensee by Company upon execution of this
                    Agreement); or

               (ii) type-written form only if used in secondary labeling,
                    advertising and promotional copy (i.e. in a sentence or
                    paragraph describing the Licensed Product), and so long as
                    the Super CitriMax trademark is accompanied by the "(R)"
                    symbol and identified as a trademark of InterHealth N.I.;
                    and

          (d)  not use, display or relate in any manner, either directly or
               indirectly, the Trademark, Product Claims or Research in
               connection with any products that do not contain Licensed Product
               and are not subject to this Agreement.

     5.   PRODUCT INFORMATION AND MATERIALS - Company provides, and will
          provide, Licensee information and materials relating to Licensed
          Product, whether proprietary or non-proprietary, whether written,
          recorded or verbal, whether on, prior or subsequent to the date of
          this Agreement, whether prepared by Company or by a third party,
          including, but not limited to, all Licensed Product sales and
          marketing materials, research data and other technical information in
          good faith and which InterHealth believes to be true and accurate
          ("Information" and "Materials"), "As Is, With All Faults," and makes,
          and will make, no representations or warranties, express or implied,
          as to the usefulness, accuracy, completeness, feasibility, reliability
          or legality of the Information and Materials. Licensee may use all
          Information and Materials prepared by or for Company solely in
          connection with the marketing and distribution of Licensed Product
          purchased from the Company or Finished Products that contain Licensed
          Product purchased from the Company and not in connection with any
          products that do not contain Licensed Product and are not subject to
          this Agreement; provided that Licensee does not in any way alter any
          of the Materials. Company may amend, add to, subtract from or
          otherwise change from time to time, the Information and/or Materials,
          in its sole and absolute discretion.

     6.   UNDERTAKINGS BY LICENSEE:

          (A)  PRODUCT CHANGES - Licensee may amend, add to, subtract from or
               otherwise change from time to time its Finished Products,
               provided that all such changes and Finished Products comply with
               the terms and conditions of this Agreement;

          (B)  PRODUCT DOSAGE - Licensee shall formulate, manufacture and label
               all Finished Product in accordance with the required dosage
               described in Exhibits A ("Required Dosage");

          (C)  LABELING STATEMENTS - Licensee shall display the required
               labeling statements described in Exhibits A ("Required Labeling
               Statements"), on or in all labeling, advertising and promotional
               materials of its Finished Products in a manner that clearly
               associates the Required Labeling Statements with the Licensed
               Product;

          (D)  PATENTS - If and when they are issued, Licensee shall list the
               number(s) of all patents issued for Licensed Product ("Patents"),
               which are appropriate to the territory(ies) in which the Finished
               Product is sold, on or in all labeling, advertising and
               promotional materials of said Finished Products in a manner that
               clearly associates the Patents with the Licensed Product
               ("Required Patent Information"). As new Patents are issued, or
               the Required Patent Information changes, Company shall notify
               Licensee in writing and Licensee shall be provided a reasonable
               amount of time to update its labeling, advertising and
               promotional materials of its Finished Products to reflect the new
               Required Patent Information;

          (E)  LABEL REVIEW - Prior to distribution of its Finished Products,
               Licensee shall provide Company copies of its Finished Product
               labeling, advertising and promotional materials for pre-market
               approval by Company, which Company shall promptly review solely
               with respect to their compliance with this Agreement. Company
               shall promptly notify Licensee in writing of its acceptance or
               rejection of Licensee's Finished Product labeling, advertising
               and promotional materials with respect to their compliance with
               this Agreement. If rejected, Company shall inform Licensee of the
               changes necessary to be in compliance with this Agreement;

          (F)  PRODUCT QUALITY - Licensee shall (i) not blend nor formulate the
               Licensed Product with any other (-)hydroxycitric acid or Garcinia
               material, and (ii) not sell any Finished Products that are not
               manufactured in accordance with the requirements of the United
               States Federal Food, Drug and Cosmetic Act, including all
               applicable good manufacturing practice regulations, or, in the
               event Finished Products are manufactured or distributed in
               countries outside the United States, in accordance with all
               applicable laws and regulations of such countries;

          (G)  PRODUCT SUPPLY - Licensee agrees that it will not resell or
               supply any Licensed Product in bulk raw material form, either
               directly or indirectly, to any other third party, except for use
               in the manufacture of Licensee's Finished Products;

          (H)  SALES RECORDS - If requested by Company, Licensee shall provide
               Company a record of its Finished Product sales within fifteen
               (15) days of Company's written request. Company shall, at its
               sole option, have the right, at its own expense, to have an
               independent accounting firm acceptable to Licensee, whose
               acceptance shall not unreasonably be withheld, audit Licensee's
               Finished Product sales records during regular business hours, no
               more than once each calendar year and with at least five (5)
               business days prior written notice.

          (I)  THIRD PARTY COMPLIANCE - Licensee shall assure compliance with
               this Agreement by any third-party manufacturer or distributor of
               Finished Products, and guarantees performance of and payment
               under Company's General Purchase Agreement by any manufacturer
               which has purchased Licensed Product from Company for the
               manufacture of Finished Products under contract with Licensee;

          (J)  NEW MARKS - Licensee may use its own trademarks, tradenames,
               logos, advertising slogans and other related marks to identify
               Licensee and its Finished Products (collectively, "Other Marks")
               in Licensee's Materials, but agrees not to combine the Trademark
               with any Other Marks, words, letters or symbols, or otherwise
               alter the Trademark, to form one or more new marks ("New Marks"),
               without the express written consent of Company, which consent
               Company may withhold at its sole and absolute discretion.
               Licensee agrees that Company is the sole and exclusive owner of
               all right, title and interest in, and to, any New Marks, except
               those rights expressly granted to Licensee;

          (K)  TRADEMARK INFRINGEMENT - Licensee shall bring to the attention of
               Company any infringement or misuse of the Trademark which comes
               to Licensee's attention. Company shall indemnify, defend and hold
               Licensee harmless from any infringement or unfair competition
               proceedings involving the Trademark so long as Licensee is using
               the Trademark in compliance with this Agreement. Licensee shall
               not assert any claim based upon misuse or infringement of the
               Trademark without the prior written consent of Company;

          (L)  COMPLIANCE WITH LAWS - Licensee will comply with all laws and
               regulations relating or pertaining to the use of the Trademark
               and marketing of Finished Products;

          (M)  EXPENSES - Licensee will not create any expenses chargeable to
               Company; and

          (N)  INDEMNIFICATION - Except as provided in Section 5(k), Licensee
               indemnifies and holds Company harmless from any claims arising
               out of any act under or in violation of this Agreement by
               Licensee and its manufacturers and/or distributors, including,
               but not limited to, the distribution, advertising and promotion
               of Licensee's Finished Products, or use of the Information or
               Materials.

          (O)  FORMULATION EXCLUSION - Licensee shall not produce, market or
               sell any Finished Product(s) that contain a combination of
               (-)hydroxycitric acid (Garcinia), chromium and gymnemic acid
               (Gymnema) material, without the express written consent of
               Company.

     7.   TERM AND TERMINATION - This Agreement shall commence on the Effective
          Date and shall continue in full force and effect, unless and until
          terminated as follows:

          (a)  Company shall have the right to terminate this Agreement upon
               written notice to Licensee upon the breach of any provision of
               this Agreement,

          (b)  Licensee shall have the right to terminate this Agreement at any
               time upon written notice to Company, or

          (c)  Licensee's failure to purchase Licensed Product from Company
               during any consecutive twelve month period of time shall
               constitute on abandonment and automatic termination of this
               Agreement.

          Upon termination of this Agreement for any reason, Licensee shall
          immediately discontinue all use of the Trademark, Product Claims,
          Research, Materials and Information, except for publicly available,
          non-proprietary Information. Sections 6(k,m,n,o), 7 and 8 shall
          survive the termination of this Agreement.

     8.   GENERAL PROVISIONS:

          (A)  ASSIGNMENT - This Agreement is personal to Licensee. Licensee
               shall not assign or transfer any rights or obligations under this
               Agreement without the prior written consent of Company; provided,
               however, that Licensee may assign to any manufacturer with which
               Licensee contracts to produce any Finished Products any rights or
               obligations reasonably necessary to enable the manufacturer to
               produce the Finished Products. Any purported assignment without
               consent except as provided in this Section 8(a) will be null and
               void. This Agreement shall inure to the benefit of and be binding
               upon the parties and their successors and assigns;

          (B)  RELATIONSHIP - The relationship of the parties to this Agreement
               is determined solely by the provisions of this Agreement. The
               parties do not intend to create any agency, partnership, joint
               venture, trust or other relationship with duties or incidents
               different from those of parties to an arm's-length contract

          (C)  CHOICE OF LAW - This Agreement shall be construed in accordance
               with, and governed by, the internal laws of the State of
               California, without regard to conflicts of law;

          (D)  INTEGRATION - This Agreement sets forth the entire understanding
               of the parties relating to the transactions it contemplates, and
               supersedes all prior understandings relating to them, whether
               written or oral. There are no obligations, commitments,
               representations or warranties relating to them except those
               expressly set forth in these Agreements;

          (E)  ATTORNEY'S FEES - if any action is necessary to enforce the terms
               of this Agreement the prevailing party shall be entitled to
               reasonable attorneys' fees in addition to any other relief to
               which it may be entitled;

          (F)  SEVERABILITY - Should all or any portion of any provision of this
               Agreement be held unenforceable or invalid for any reason, the
               remaining portions or provisions shall be unaffected; and

          (G)  WEIVER/MODIFICATION/ AMENDMENT - No amendment of, supplement to
               or waiver of any obligations under this Agreement will be
               enforceable or admissible unless set forth in a writing signed by
               the party against which enforcement or admission is sought. No
               delay or failure to require performance of any provision of this
               Agreement shall constitute a waiver of that provision as to that
               or any other instance. Any waiver granted shall apply solely to
               the specific instance expressly stated.

IN WITNESS WHEREOF the parties have executed this Agreement as of the date
first written above.

LICENSEE

Company: Creative Enterprises Intl., Inc.
A Nevada Corporation
Address: 825 Lafayette Road
City, State, Zip: Bryn Mawn, Pa. 19010

Signature: /s/ Michael Salaman
           --------------------------
Name (Print): Michael Salaman
Title: President

COMPANY (INTERHEALTH)

SIGNATURE: /s/ Illegible
           --------------------------
Name (Print): _______________________
Title: EXEC. VP

                               EXHIBIT A - PRODUCT

PRODUCT NAME                        Super CitriMax(R) Clinical Strength

DESCRIPTION                         High solubility, non-hygroscopic, low
                                    sodium, potassium/calcium salt of
                                    (-)hydroxycitric acid extract, from the
                                    dried fruit rind of Garcinia cambogia
                                    (patent pending).

PRODUCT TYPES

   HCA-600-SXG                      Coarse powder for tableting and some
                                    encapsulating applications.

   HCA-6OO-SXM                      Medium mesh powder for multipurpose
                                    applications.

   HCA-600-SXS                      Soluble fine powder for food and beverage
                                    and some encapsulating applications.

SPECIFICATIONS*

   (-)Hydroxycitric Acid (mg/g)     600 +/- 50
   Calcium (mg/g)                   110 +/- 30
   Potassium (mg/g)                 160 +/- 40
   Sodium (mg/g)                    Less than 10

* For additional specifications, see Company's HCA-600-SXG, -SXM and -SXS
product specification sheets.

REQUIRED DOSAGE

   For dietary supplements          4500 mgs material providing 2700 mgs
                                    (-)hydroxycitric acid per day taken in three
                                    divided doses 30-60 minutes before meals.

   For functional foods and         1500 mgs material providing 900 mgs
   beverages                        (-)hydroxycitric acid per serving.
                                    Recommended three servings per day.

REQUIRED LABELING STATEMENTS

   (See Super CitriMax(R)           Super CitriMax(R) is a trademark of
   Clinical Strength Labeling       InterHealth N.I.
   Guidelines for correct usage     Super CitriMax brand of (-)hydroxycitric
   of Required Labeling             acid (patents-pending).
   Statements.)

REQUIRED PATENT INFORMATION*

     All countries         Patents-pending

     * To be listed in the Required Labeling Statement as indicated above or
     elsewhere in the labeling, advertising and promotional materials of
     Licensee's Finished Products in a manner that clearly associates the
     Patents and/or Patents Pending with the Licensed Product.

SUPER CITRIMAX CLINICAL STRENGTH LICENSING AGREEMENT
                                              FORM SCX-CS-TLA.DOC--March 3, 2004

                              EXHIBIT B - RESEARCH

PUBLICATIONS

     1.   Ohia SE, Awe O, LeDay AM, Opere CA, Bagchi D, Effect of Hydroxycitric
          Acid on Serotonin Release from Isolated Rat Brain Cortex, Research
          Communications in Molecular Pathology and Pharmacology,
          109:210-216, 2001.

     2.   Loe YC, Bergeron N, Rodriguez N, Schwarz J-M, Gas Chromatography/Mass
          Spectrometry Method to Quantify Blood Hydroxycitrate Concentration,
          Analytical Biochemistry, 292:148-154, 2001.

     3.   Westerterp-Plantenga MS, Kovacs EMR, The Effect of (-)-Hydroxycitrate
          on Energy Intake and Satiety in Overweight Humans. International
          Journal of Obesity, 26:870-872, 2002.

     4.   Ohia SE, Opere CA, LeDay AM, Bagchi M, Bagchi D, Stohs SJ, Safety and
          Mechanism of Appetite Suppression by a Novel Hydroxycitric Acid
          Extract (HCA-SX), Molecular and Cellular Biochemistry, 238: 89-103,
          2002.

     5.   Shara M, Ohia SE, Yasmin T, Zardetto-Smith A, Kincaid A, Bagchi M,
          Chatterjee A, Bagchi D, Stohs SJ, Dose- and Time-Dependent Effects of
          a Novel (-)-Hydroxycitric Acid Extract on Body Weight, Hepatic and
          Testicular Lipid Peroxidation, DNA Fragmentation and Histopathological
          Data over a Period of 90 D, Molecular and Cellular Biochemistry,
          254:339-346, 2003.

     6.   Preuss HG, Bagchi D, Bagchi M, Rao CVS, Satyanarayana S, Dey DK,
          Efficacy of a Novel, Natural Extract of (-)-Hydroxycitric Acid
          (HCA-SX) and a Combination of HCA-SX, Niacin-Bound Chromium and
          Gymnema sylvestre Extract in Eight Management in Human Volunteers,
          Nutrition Research 24:45-58, 2004.

     7.   Preuss HG, Bagchi D, Bagchi M, Rao CVS, Dey DK and Satyanarayana S,
          Efficacy of a Novel, Natural Extract of (-)-Hydroxycitric Acid
          (HCA-SX) and a Combination of HCA-SX, Niacin-Bound Chromium and
          Gymnema sylvestre Extract in Weight Loss, Diabetes, Obesity and
          Metabolism (In Press).

     8.   Shara M, Ohia SE, Schmidt RE, Yasmin T, Zardetto-Smith A, Kincaid A,
          Bagchi M, Chatterjee A, Bagchi D and Stohs SJ, Physico-chemical
          Properties of a Novel (-)-Hydroxycitric Acid Extract and Its Dose-and
          Time-dependent Effects on body Weight, Selected Organ Weights, Hepatic
          Lipid Peroxidation and DNA Fragmentation, Hematology and Clinical
          Chemistry, and Histopathological Changes Over a Period of 90 Days,
          Molecular and Cellular Biochemistry (In Press).

ABSTRACTS

     1.   Loe YC, Rodriguez N, Schwarz J-M, A New Mass Spectrometric Method to
          Quantify Blood Hydroxycitrate Concentration in Human Subjects, The
          FASEB Journal, 14:A212, Abs. 158.1, 2000.

     2.   Loe YC, Bergeron N, Phan J, Wen M, Lee J, Schwarz J-M, Time Course of
          Hydroxycitrate Clearance in Fasting and Fed Humans, The FASEB Journal,
          15:A632, Abs. 501.1, 2001.

     3.   Ohia SE, Awe SO, LeDay AM, Bagchi D, Effect of Hydroxycitric Acid on
          [(3)H]-5-HT Release from Rat Brain Cortex, The FASEB Journal, 15:A224,
          Abs. 207.13, 2001.

     4.   Ohia SE, Opere CA, LeDay AM, Bagchi M, Bagchi D, Mechanism of Appetite
          Suppresion by a Novel, Natural Hydroxycitric Acid, The Toxicologist,
          66 (1-S):188-189, Abs. 921, 2002.

     5.   Preuss HG, Bagchi D, Rao CVS, Echard BW, Satyanarayana S, Bagchi M,
          Effect of Hydroxycitric Acid on Weight Loss, Body Mass Index and
          Plasma Leptin Levels in Human Subjects, The FASEB Journal 16:A1020,
          Abs. 742.16, 2002.

     6.   Bagchi D, Preuss HG, Ohia SE, Rao CVS, Satyanarayana S, Bagchi M,
          Weight Management and Mechanism of Appetite Suppression by a Novel,
          Natural Extract of (-)-Hydroxycitric Acid, International Scientific
          Conference on Complimentary, Alternative & Integrative Medicine
          Research-Harvard University, Boston, MA, 9, Abs. 141, April
          12-14, 2002.

     7.   Bagchi D, Preuss HG, Rao CVS, Satyanarayana S, Bagchi M, Weight
          Management and Mechanisms of Action of a Novel, Natural Extract of
          (-)-Hydroxycitric Acid (HCA-SX) and a Combination of HCA-SX

SUPER CITRIMAX CLINICAL STRENGTH LICENSING AGREEMENT
                                              FORM SCX-CS-TLA.DOC--March 3, 2004

          Plus Niacin-Bound Chromium (NBC) and Gymnema sylvestre Extract (GSE),
          9th International Congress on Clinical Nutrition, London, UK, Abs.
          AB041, June 24-26, 2002.

     8.   Bagchi M, Preuss HG, Rao CVS, Bagchi D, Efficacy of a novel
          (-)-Hydroxycitric Acid Extract in Weight Management, Journal of the
          American College of Nutrition, 21:481, Abs. 61, 2002.

     9.   Bagchi D, Preuss HG, Rao CVS, Satyanarayana S, Bagchi M, Mechanisms of
          Weight Management by a Novel, Natural Extract of (-)-Hydroxycitric
          Acid (HCA-SX) and a Combination of HCA-SX Plus Niacin-Bound Chromium
          (NBC) and Gymnema sylvestre Extract (GSE), Journal of Tumor Marker
          Oncology, 17:55, Abs. A18, 2002.

     10.  Bagchi D, Preuss HG, Ohia SE, Rao CVS, Satyanarayana S and Bagchi M,
          Weight Management and Mechanism of Appetite Suppression by a Novel,
          Natural Extract of (-)-Hydroxycitric Acid, International Scientific
          Conference on Complementary, Alternative & Integrative Medicine
          Research, Boston, MA, April 12-14, 2002.

     11.  Debasis B, Weight Management & Mechanism of Appetite Suppression by a
          Natural Extract of (-)-Hydroxycitric Acid & a Combination of HCA-SX
          Plus Niacin-Bound Chromium (NBC) & Gymnema Sylvestre Extract (GSE),
          American Society of Bariatric Physicians Western Regional Obesity
          Course, Denver, CO, May 16-18, 2002.

     12.  Bagchi D, Preuss HG, Ohia SE, Rao CVS, Satyanarayana S and Bagchi M,
          Mechanism of Weight Management by a Novel, Natural Extract of
          (-)-Hydroxycitric Acid (HCA-SX) and a Combination of HCA-SX Plus
          Niacin-Bound Chromium (NBC) and Gymnema Sylvestre Extract (GSE), The
          2nd International Conference on Mechanisms and Actions of
          Nutraceuticals, Krems - Danube, Austria, October 6-9, 2002.

     13.  Ohia SE, Stohs SJ, Shara M, Yasmin T, Chatterjee A, Bagchi M,
          Zardetto-Smith A, Kincaid A and Bagchi D, 90-Day Chronic Toxicity
          Study of a Novel (-)-Hydroxycitric Acid Extract of Garcinia Cambogia,
          Society of Toxicology 42nd Annual Meeting & ToxExpo, Salt Lake City,
          Utah, March 9-13, 2003.

     14.  Bagchi D, Preuss HG, Ohia SE and Bagchi M, Molecular Mechanisms of
          Weight Management by a Novel, Natural Extract of (-)-Hydroxycitric
          Acid, 2003 American Association of Integrative Medicine (AAIM)
          National Conference San Antonio, TX, August 22-24, 2003.

SUPER CITRIMAX CLINICAL STRENGTH LICENSING AGREEMENT
                                              FORM SCX-CS-TLA.DOC--March 3, 2004

                           EXHIBIT C - TRADEMARK LOGO

Logo style for use in conjunction with Licensed Product (contact InterHealth for
electronic file):

[SuperCitrimax(R) LOGO]
Clinical Strength

SUPER CITRIMAX CLINICAL STRENGTH LICENSING AGREEMENT
                                              FORM SCX-CS-TLA.DOC--March 3, 2004

                       SUPER CITRIMAX(R) CLINICAL STRENGTH
                              MARKETING AGREEMENT

This agreement ("Agreement") is entered into this 9th day of June, 2004 by
InterHealth Nutraceuticals Incorporated, a California Corporation with its
principal place of business at 5451 Industrial Way, Benicia, CA 94510
("InterHealth") and Creative Enterprises Intl., Inc., a Nevada corporation with
its principal place of business at 825 Lafayette Road, Bryn Mawr, PA 19010
("Customer").

Whereas, InterHealth markets, distributes and sells a nutritional weight loss
ingredient under the tradename "Super CitriMax(R) Clinical Strength"
("Trademark"), which (a) is sold as a nutritional supplement, (b) is the subject
of certain patents pending ("Patents Pending"), and (c) meets the specifications
described in Exhibit A attached hereto, which may be updated in writing by
InterHealth from time to time (collectively referred to as "Product");

Whereas, Customer wishes to sell, market and distribute Product to be packaged
by Customer in end-user, finished packaged form as a nutritional supplement in
bottled water form only ("Finished Product") through Mass Market ("Channel")
located in the Untied States of America and it territories, Croatia, Australia,
Malaysia, Austria, Mexico, Belgium, New Zealand, Canada, Poland, Czech Republic,
Russia, Finland, South Africa, France, Sweden, Germany, Taiwan, Hong Kong,
Thailand, Japan, The Netherlands, Korea, United Kingdom ("Territory"); and

Whereas, InterHealth appoints Customer to sell Finished Product on a
non-exclusive basis in the Channel and in the Territory.

Customer agrees to:

     1.   Use commercially reasonable efforts to sell, distribute, advertise and
          promote Finished Product in the Channel and in the Territory solely
          under its Skinny Water brand.

     2.   Execute and comply with the terms of the Super CitriMax(R) Clinical
          Strength Licensing Agreement, including but not limited to, (a)
          Finished Product dosage and recommended use requirements, and (b)
          Finished Product labeling requirements, including (i) displaying the
          Trademark logo and identifying the Trademark as "a trademark of
          InterHealth N.I.," (ii) using the term "patent pending" in describing
          the Product, and (iii) listing all Patent numbers, as they are issued,
          on all packaging, advertising and promotional materials of Finished
          Product.

InterHealth agrees to:

     1.   Use commercially reasonable efforts to promptly fill Customer's orders
          for Product and to supply Product to Customer according to
          specifications.

     2.   Use commercially reasonable efforts to provide (a) technical support
          to Customer regarding Product, including information about the
          Product's safety and efficacy, physical and chemical properties, and
          applications and uses, and (b) ongoing marketing, research and
          intellectual property support for Product, to the extent InterHealth
          deems prudent.

     3.   Sell Product to Customer at the price of [****] F.O.B. Benicia,
          CA 94510. Said price shall apply to sales of Product to Customer,
          which are intended for use in the manufacture of Finished Product
          under the Skinny Water brand to be sold in the Channel and in the
          Territory only, and is subject to change upon 30 days written notice.

[*Certain information on this page has been omitted and filed separately with
the Commission. Confidential treatment has been requested with respect to the
omitted portions.]

______________________________________________________________________

___________                   ___________

/s/ Illegible        6/4/04   /s/ Illegible       6/22/04
------------------    Date    -----------------     Date
__________________            _________________

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00097-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00097-of-00352.parquet"}]]